Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pixience develops advanced medical imaging devices and AI-powered software to facilitate early detection of skin cancer and support dermatological research. Their flagship products—C-Cube suite for high-definition color-calibrated skin imaging with both 2D/3D capabilities—are used by clinicians for diagnosis as well as by researchers in clinical trials. The company’s solutions are deployed commercially in France since at least 2019. Recent partnerships include use of their technology in nutricosmetic ingredient trials.
Clinical results per se are not published; the company’s value lies in enabling accurate measurement/data collection for others’ clinical studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pixience.